Go Pro

Weiss Ratings' Rating of 20/20 Biolabs on 5/14/2026

On May 14, 2026, Weiss Ratings updated its outlook on 20/20 Biolabs (NASDAQ:AIDX) with the action "Initiated Coverage", setting a "Sell (E-)" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Weiss Ratings

DateCompanyAction
7/2/2026
Wah Fu Education Group Limited stock logo
WAFU
Wah Fu Education Group
Reiterated Rating
7/2/2026
Turbo Energy, S.A. stock logo
TURB
Turbo Energy
Reiterated Rating
7/2/2026
TNL Mediagene stock logo
TNMG
TNL Mediagene
Reiterated Rating
7/2/2026
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
Reiterated Rating
7/2/2026
The Children's Place, Inc. stock logo
PLCE
Children's Place
Reiterated Rating
7/2/2026
Bank of N.T. Butterfield & Son Limited (The) stock logo
NTB
Bank of N.T. Butterfield & Son
Reiterated Rating
More Ratings From Weiss Ratings